1. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure 
Erin M. Schumer, MD, Mickey S. Ising, MEng, Jaimin R. Trivedi, MD, MPH, Mark S. Slaughter, MD, Allen Cheng, MD 
The Annals of Thoracic Surgery 
Volume 100, Issue 2, Pages (August 2015)
DOI: /j.athoracsur
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Flow chart of selection of patients for analysis using the United Network for Organ Sharing database. The left-ventricular assist device group, n = 2,561; marginal donor group, n = 4,737. (HMII = Heart-Mate II; HVAD = heart ventricular assist device; MCS = mechanical circulatory support device.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Annual case count from 2005 to 2013 for left ventricular assist device (LVAD) placement and marginal donor heart transplantations. The LVAD cases are counted at time of listing while marginal donor heart transplantations are counted at time of transplant.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Kaplan-Meier survival analysis comparing all-cause mortality for continuous flow left ventricular assist device (LVAD) pre-transplant recipients and recipients of marginal donor hearts post-transplantation.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

5. Fig 4
Kaplan-Meier survival analysis comparing all-cause mortality for post-transplantation survival for patients implanted with a left ventricular assist device (LVAD) and recipients of marginal donor hearts.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions